A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma:: a detection strategy

被引:20
作者
Dang, GT
Cote, GJ
Schultz, PN
Khorana, S
Decker, RA
Gagel, RF
机构
[1] Univ Texas, MD Anderson Cancer Ctr, Sect Endocrine Neoplasia & Hormone Disorders, Houston, TX 77030 USA
[2] Decker Fdn, Charlie Hays Div Canc Res, St Louis, MO 63105 USA
关键词
RET proto-oncogene; MEN; 2; FMTC;
D O I
10.1006/mcpr.1998.0220
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A ser891ala RET proto-oncogene mutation has been previously discovered in a single kindred with familial medullary thyroid carcinoma (FMTC). An additional two probands with this mutation and with medullary thyroid carcinoma (MTC) without any other manifestations of MEN 2 have been identified. In one of thse families, two Other individuals also had the mutant sequence and FMTC. Analysis of both cases showed cosegregation of he mutation and MTC. To facilitate detection of this mutation, a primer was engineered which creates a Hha I recognition site in the presence of the mutant sequence. As a result, this codon 891 exon 15 mutation can be identified with a restriction enzyme digestion. (C) 1999 Academic Press.
引用
收藏
页码:77 / 79
页数:3
相关论文
共 17 条
  • [1] BOLINO A, 1995, ONCOGENE, V10, P2415
  • [2] Decker RA, 1997, CANCER, V80, P557, DOI 10.1002/(SICI)1097-0142(19970801)80:3+<557::AID-CNCR5>3.3.CO
  • [3] 2-H
  • [4] Hirschsprung disease in MEN 2A:: increased spectrum of RET exon 10 genotypes and strong genotype-phenotype correlation
    Decker, RA
    Peacock, ML
    Watson, P
    [J]. HUMAN MOLECULAR GENETICS, 1998, 7 (01) : 129 - 134
  • [5] MUTATIONS IN THE RET PROTOONCOGENE ARE ASSOCIATED WITH MEN 2A AND FMTC
    DONISKELLER, H
    DOU, SS
    CHI, D
    CARLSON, KM
    TOSHIMA, K
    LAIRMORE, TC
    HOWE, JR
    MOLEY, JF
    GOODFELLOW, P
    WELLS, SA
    [J]. HUMAN MOLECULAR GENETICS, 1993, 2 (07) : 851 - 856
  • [6] ENG C, 1995, ONCOGENE, V10, P509
  • [7] The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2 - International RET mutation consortium analysis
    Eng, C
    Clayton, D
    Schuffenecker, I
    Lenoir, G
    Cote, G
    Gagel, RF
    vanAmstel, HKP
    Lips, CJM
    Nishisho, I
    Takai, SI
    Marsh, DJ
    Robinson, BG
    FrankRaue, K
    Raue, F
    Xue, FY
    Noll, WW
    Romei, C
    Pacini, F
    Fink, M
    Niederle, B
    Zedenius, J
    Nordenskjold, M
    Komminoth, P
    Hendy, GN
    Gharib, H
    Thibodeau, SN
    Lacroix, A
    Frilling, A
    Ponder, BAJ
    Mulligan, LM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (19): : 1575 - 1579
  • [8] Fattoruso O, 1998, HUM MUTAT, pS167
  • [9] A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma
    Hofstra, RMW
    Fattoruso, O
    Quadro, L
    Wu, Y
    Libroia, A
    Verga, U
    Colantuoni, V
    Buys, CHCM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) : 4176 - 4178
  • [10] DIRECT SEQUENCING OF PCR PRODUCTS IN AGAROSE-GEL SLICES
    KHORANA, S
    GAGEL, RF
    COTE, GJ
    [J]. NUCLEIC ACIDS RESEARCH, 1994, 22 (16) : 3425 - 3426